Related Experiment Videos
Lambert-eaton myasthenic syndrome.
Frontiers of Neurology and Neuroscience
|April 8, 2009
Summary
Lambert-Eaton myasthenic syndrome (LEMS) is a rare autoimmune disorder impacting nerve-muscle connections. Early diagnosis is crucial as LEMS often signals early-stage lung cancer.
Area of Science:
- Neurology
- Autoimmune Disorders
- Oncology
Background:
- Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder affecting the presynaptic neuromuscular junction.
- LEMS is a rare disease with significant implications due to its strong association with underlying lung cancer.
- Subtle clinical features and insidious onset contribute to diagnostic delays, often spanning months to years.
Purpose of the Study:
- To highlight the importance of clinical recognition and diagnosis of Lambert-Eaton myasthenic syndrome.
- To emphasize the critical link between LEMS and early-stage lung cancer detection.
- To underscore the challenges in diagnosing LEMS due to its subtle presentation.
Main Methods:
- Review of clinical presentations and diagnostic challenges in LEMS.
- Analysis of the association between LEMS and underlying malignancies, particularly lung cancer.
- Discussion of diagnostic delays and their impact on patient outcomes.
Main Results:
- LEMS diagnosis is critical for identifying early-stage lung cancer.
- Diagnostic delays are common due to the subtle and insidious nature of LEMS symptoms.
- Prompt recognition of LEMS can lead to earlier cancer detection and potentially improved prognosis.
Conclusions:
- Early and accurate diagnosis of Lambert-Eaton myasthenic syndrome is paramount.
- LEMS serves as an important paraneoplastic syndrome, often indicating occult lung cancer.
- Increased awareness and timely diagnostic approaches for LEMS are essential for patient management.
Related Concept Videos
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:28Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:26Cross-bridge Cycle
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...